← Leaderboards
Zhiwei Hu
Ohio State University
$584,703
Attributed
$801,265
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $433.1K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$801,265 · 2
By mechanism
R21$801,265 · 2
Top collaborators
- Hua Zhu1 shared
Most similar at Ohio State University
Same institution · by research overlap
- Heather Chandler$2,907,094
- Hua Zhu$6,731,822
- Michael D Twa$2,361,841
- Frederick H Davidorf$73,178
- Mohamed H. Abdel-Rahman$3,602,822
Others in their field
Other Emerging Leaders on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Jay Evans · University Of Montana$23,628,886
- Alan D. Palkowitz · Indiana University Indianapolis$21,600,744
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
- Xinhua Li · Nano Terra, Inc.$11,962,715
- Gregory L Hura · University Of Calif-Lawrenc Berkeley Lab$10,638,609
Research focus
LigandsMutationEffective TherapyLegal PatentMacular DegenerationMouse ModelCellsDesignEnzyme PrecursorsImmunotherapyLightLysineAmino AcidsMalignant NeoplasmsBlood Coagulation Factor ViiAlanineCoagulation ProcessCombined Modality TherapyEndometriosisEndothelial CellsGenerationsIgg1Animal ModelNames
Grant awards (3)
Inhibiting Corneal Neovascularization by Targeting Tissue Factor$433,125
R21 · FY2025 · EY
Targeting tissue factor as a novel oncotarget for immunotherapy of triple negative breast cancer$164,560
R21 · FY2019 · CA · contact PI
Targeting tissue factor as a novel oncotarget for immunotherapy of triple negative breast cancer$203,580
R21 · FY2018 · CA · contact PI